Presenters
Jim Wilkinson, PhD
U.S. Medical Affairs Lead (Immunology & Payer), Medical Affairs & Evidence Gener, Argenx, United States
Jim Wilkinson, PhD is an executive leader in global and US Medical Affairs, with over 20 years in the biopharma industry. Currently at Argenx, his experience includes leading Global/US Medical Information, Global Publications, Global/US Medical Communications, Global Field-Based Medical, and US Medical Science Liaison (MSL) teams. Jim has worked in multiple therapeutic areas while also launching multiple products throughout the course of his career. He has extensive working knowledge of the commercialization process, compliance, product launches, company/product acquisition and integration, legal and regulatory guidelines, operations, digital, and promotional review. Jim received his B.S. from UW-Madison and his Ph.D. from UM-Minneapolis.
Peter Baumeister, PhD
Director, Global Medical and Scientific Affairs, Merck Sharp & Dohme LLC , United States
Dr. Peter Baumeister is currently a Medical Affairs professional with a career history that includes clinical and emergency medicine, basic science research, active duty enlistment in the Air Force and a short stint in art school that continues to supply him with entertaining anecdotes. He currently lives in Southern California, where he enjoys challenging the laws of physics with his eternally patient wife and 3 kids, all of whom are well-versed in basic first aid and trauma care. Professionally, he is interested in the sweet spot at the intersection of people, process, and technology in Medical Affairs and works to bring teams together that experience success greater than the sum of its individuals.
Michelle Clausen, PharmD, RPh
Senior Director, Chief Medical Office- Strategy & Innovation Team, Pfizer, Inc., United States
Michelle Clausen is Senior Director and lead of the Pfizer Medical Strategy and Innovation Team which supports the Chief Medical Office at Pfizer. Michelle has 17 years experience in industry working across various roles within Medical Communications and now leads a team with a mission of driving strategy through innovation and insights to accelerate and advance the value of division’s contribution towards a healthier world. The team focuses on data & analytics, strategic communications, and innovative projects in collaboration with the groups they support. Michelle has her Doctor of Pharmacy (Shenandoah School of Pharmacy) and BS in Pharmacy (Rutgers College of Pharmacy).
Have an account?